{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:42:46Z","timestamp":1773157366889,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1007\/s11899-006-0005-8","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T05:24:49Z","timestamp":1180070689000},"page":"241-247","source":"Crossref","is-referenced-by-count":7,"title":["Lymphoblastic lymphoma in adults"],"prefix":"10.1007","volume":"1","author":[{"given":"John W.","family":"Sweetenham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5_CR1","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","volume":"89","author":"The Non-Hodgkin\u2019s Lymphoma Classification Project","year":"1997","unstructured":"The Non-Hodgkin\u2019s Lymphoma Classification Project: A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. Blood 1997, 89:3909\u20133918.","journal-title":"Blood"},{"key":"5_CR2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7326\/0003-4819-89-3-319","volume":"89","author":"PJ Rosen","year":"1978","unstructured":"Rosen PJ, Feinstein DI, Pattengale PK, et al.: Convoluted lymphocytic lymphoma in adults: a clinicopathological entity. Ann Intern Med 1978, 89:319\u2013324.","journal-title":"Ann Intern Med"},{"key":"5_CR3","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1002\/1097-0142(19811201)48:11<2347::AID-CNCR2820481102>3.0.CO;2-X","volume":"48","author":"BN Nathwani","year":"1978","unstructured":"Nathwani BN, Diamond LW, Winberg CD, et al.: Lymphoblastic lymphoma: a clinicopathologic study of 95 patients. Cancer 1978, 48:2347\u20132357.","journal-title":"Cancer"},{"key":"5_CR4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1309\/K2FY1TED8GEGFLNG","volume":"121","author":"S Li","year":"2004","unstructured":"Li S, Juco J, Mann KP, Holden JT: Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia\/lymphoblastic lymphoma. Am J Clin Pathol 2004, 121:268\u2013274.","journal-title":"Am J Clin Pathol"},{"key":"5_CR5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/1097-0142(19870715)60:2<183::AID-CNCR2820600211>3.0.CO;2-0","volume":"60","author":"K Sheibani","year":"1987","unstructured":"Sheibani K, Nathwani BN, Winberg CD, et al.: Antigenically defined subgroups of lymphoblastic lymphoma: relationship to clinical presentation and biologic behavior. Cancer 1987, 60:183\u2013190.","journal-title":"Cancer"},{"key":"5_CR6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1172\/JCI111954","volume":"76","author":"MP Link","year":"1985","unstructured":"Link MP, Stewart SJ, Warnke RA, et al.: Discordance between surface and cytoplasmic expression of the Leu-4 (T3) antigen in thymocytes and in blast cells from childhood lymphoblastic malignancies. J Clin Invest 1985, 76:248\u2013253.","journal-title":"J Clin Invest"},{"key":"5_CR7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/modpathol.3800079","volume":"17","author":"N Kiyokawa","year":"2004","unstructured":"Kiyokawa N, Sekino T, Matsui T, et al.: Diagnostic importance of CD179a\/b as markers of precursor B-cell lymphoblastic lymphoma. Mod Pathol 2004, 17:423\u2013429.","journal-title":"Mod Pathol"},{"key":"5_CR8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/(SICI)1096-9896(199907)188:3<267::AID-PATH357>3.0.CO;2-N","volume":"188","author":"E Pilozzi","year":"1999","unstructured":"Pilozzi E, Muller-Hermelink HK, Falini B, et al.: Gene rearrangements in T-cell lymphoblastic lymphoma. J Pathol 1999, 188:267\u2013270.","journal-title":"J Pathol"},{"key":"5_CR9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1084-8592(96)70029-2","volume":"1","author":"T Okuda","year":"1996","unstructured":"Okuda T, Fisher R, Downing JR: Molecular diagnostics in pediatric acute lymphoblastic leukemia. Mol Diagn 1996, 1:139\u2013151.","journal-title":"Mol Diagn"},{"key":"5_CR10","doi-asserted-by":"crossref","unstructured":"Ferrando AA, Neuberg DS, Staunton J, et al.: Gene expression signatures define novel oncogenic pathways in acute lymphoblastic leukemia. Cancer Cell 2002, 75\u201387.","DOI":"10.1016\/S1535-6108(02)00018-1"},{"key":"5_CR11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1182\/blood-2003-05-1495","volume":"103","author":"H Cave","year":"2004","unstructured":"Cave H, Suciu S, Preudhomme C, et al.: Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951. Blood 2004, 103:442\u2013450.","journal-title":"Blood"},{"key":"5_CR12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/10428199409049726","volume":"15","author":"JP Colgan","year":"1994","unstructured":"Colgan JP, Andersen J, Habermann TM, et al.: Long-term follow-up of a CHOP-based regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin\u2019s lymphoma. Leuk Lymphoma 1994, 15:291\u2013296.","journal-title":"Leuk Lymphoma"},{"key":"5_CR13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/10428199909145953","volume":"36","author":"U Kaiser","year":"1999","unstructured":"Kaiser U, Uebelacker I, Havemann K: Non-Hodgkin\u2019s lymphoma protocols in the treatment of patients with Burkitt\u2019s lymphoma and lymphoblastic lymphoma: a report on 58 patients. Leuk Lymphoma 1999, 36:101\u2013108.","journal-title":"Leuk Lymphoma"},{"key":"5_CR14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/oxfordjournals.annonc.a059214","volume":"6","author":"LM Jost","year":"1995","unstructured":"Jost LM, Jacky E, Dommann-Scherrer C, et al.: Short-term weekly chemotherapy followed by high dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt\u2019s lymphomas in adult patients. Ann Oncol 1995, 6:445\u2013451.","journal-title":"Ann Oncol"},{"key":"5_CR15","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/sj.leu.2403095","volume":"17","author":"S Gouill Le","year":"2003","unstructured":"Le Gouill S, Lepretre S, Briere J, et al.: Adult lymphoblastic lymphoma: a retrospective analysis of 92 patients under 61 years included in the LNH87\/93 trials. Leukemia 2003, 17:2220\u20132224.","journal-title":"Leukemia"},{"key":"5_CR16","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/sj.leu.2403733","volume":"19","author":"GW Imhoff van","year":"2005","unstructured":"van Imhoff GW, van der Holt B, MacKenzie MA, et al.: Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma. Leukemia 2005, 19:945\u2013952. An important \"negative\" study demonstrating that the use of autologous stem cell transplantation does not substitute for intensive induction chemotherapy, CNS prophylaxis, and consolidation\/maintenance therapy as used in acute lymphoblastic leukemia.","journal-title":"Leukemia"},{"key":"5_CR17","doi-asserted-by":"crossref","first-page":"19990","DOI":"10.1002\/1097-0142(197912)44:6<1990::AID-CNCR2820440605>3.0.CO;2-9","volume":"44","author":"N Wollner","year":"1979","unstructured":"Wollner N, Burchenal JH, Lieberman PH, et al.: Non-Hodgkin\u2019s lymphoma in children. A progress report on the original patients treated with the LSA2-L2 protocol. Cancer 1979, 44:19990\u20131999.","journal-title":"Cancer"},{"key":"5_CR18","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/cncr.11615","volume":"98","author":"J Mora","year":"2003","unstructured":"Mora J, Filippa DA, Qin J, Wollner N: Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial Sloan-Kettering Cancer Center. Cancer 2003, 98:1283\u20131291.","journal-title":"Cancer"},{"key":"5_CR19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1056\/NEJM198303103081003","volume":"308","author":"JR Anderson","year":"1983","unstructured":"Anderson JR, Wilson JF, Jenkin DT, et al.: Childhood non-Hodgkin\u2019s lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2). N Engl J Med 1983, 308:559\u2013565.","journal-title":"N Engl J Med"},{"key":"5_CR20","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1182\/blood.V57.4.679.679","volume":"57","author":"CN Coleman","year":"1981","unstructured":"Coleman CN, Cohen JR, Burke JS, Rosenberg SA: Lymphoblastic lymphoma in adults: results of a pilot protocol. Blood 1981, 57:679\u2013684.","journal-title":"Blood"},{"key":"5_CR21","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1200\/JCO.1986.4.11.1628","volume":"4","author":"CN Coleman","year":"1986","unstructured":"Coleman CN, Picozzi VJ Jr, Cox RS, et al.: Treatment of lymphoblastic lymphoma in adults. J Clin Oncol 1986, 4:1628\u20131637.","journal-title":"J Clin Oncol"},{"key":"5_CR22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1200\/JCO.1986.4.1.57","volume":"4","author":"DE Slater","year":"1986","unstructured":"Slater DE, Mertelsmann R, Koziner B, et al.: Lymphoblastic lymphoma in adults. J Clin Oncol 1986, 4:57\u201367.","journal-title":"J Clin Oncol"},{"key":"5_CR23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/oxfordjournals.annonc.a057692","volume":"1","author":"C Bernasconi","year":"1990","unstructured":"Bernasconi C, Brusamolino E, Lazzarino M, et al.: Lymphoblastic lymphoma in adult patients: clinicopathological features and response to intensive multiagent chemotherapy analogous to that used in acute lymphoblastic leukemia. Ann Oncol 1990, 1:141\u2013146.","journal-title":"Ann Oncol"},{"key":"5_CR24","first-page":"745a","volume":"86","author":"S Daenen","year":"1995","unstructured":"Daenen S, van Imhoff GW, Haaxma-Reiche H, et al.: Acute lymphoblastic leukemia: single center experience with modified chemotherapy [abstract]. Blood 1995, 86:745a.","journal-title":"Blood"},{"key":"5_CR25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/10428199609054867","volume":"23","author":"PL Zinzani","year":"1996","unstructured":"Zinzani PL, Bendandi M, Visani G, et al.: Adult lymphoblastic lymphoma: clinical features and prognostic factors in 53 patients. Leuk Lymphoma 1996, 23:577\u2013582.","journal-title":"Leuk Lymphoma"},{"key":"5_CR26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1023\/A:1008202808144","volume":"9","author":"R Bouabdallah","year":"1998","unstructured":"Bouabdallah R, Xerri L, Bardou VJ, et al.: Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: a report on 62 patients from a single center. Ann Oncol 1998, 9:619\u2013625.","journal-title":"Ann Oncol"},{"key":"5_CR27","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1182\/blood-2002-01-0110","volume":"99","author":"D Hoelzer","year":"2002","unstructured":"Hoelzer D, G\u00f6kbuget N, Digel W, et al.: Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood 2002, 99:4379\u20134385.","journal-title":"Blood"},{"key":"5_CR28","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1182\/blood-2003-12-4428","volume":"104","author":"DA Thomas","year":"2004","unstructured":"Thomas DA, O\u2019Brian S, Cortes J, et al.: Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma. Blood 2004, 104:1624\u20131630.","journal-title":"Blood"},{"key":"5_CR29","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1002\/cncr.10552","volume":"94","author":"BS Dabaja","year":"2002","unstructured":"Dabaja BS, Ha CS, Thomas DA, et al.: The role of local radiation therapy for mediastinal disease in adults with Tcell lymphoblastic lymphoma. Cancer 2002, 94:2738\u20132744.","journal-title":"Cancer"},{"key":"5_CR30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2141.1989.tb00224.x","volume":"73","author":"N Milpied","year":"1989","unstructured":"Milpied N, Ifrah N, Kuentz M, et al.: Bone marrow transplantation for adult poor prognosis lymphoblastic lymphoma in first complete remission. Br J Haematol 1989, 73:82\u201387.","journal-title":"Br J Haematol"},{"key":"5_CR31","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1200\/JCO.1992.10.4.644","volume":"10","author":"LF Verdonck","year":"1992","unstructured":"Verdonck LF, Dekker AW, de Gast GC, et al.: Autologous bone marrow transplantation for adult poor-risk lymphoblastic lymphoma in first remission. J Clin Oncol 1992, 10:644\u2013646.","journal-title":"J Clin Oncol"},{"key":"5_CR32","first-page":"33","volume":"10","author":"J Baro","year":"1992","unstructured":"Baro J, Richard C, Sierra J, et al.: Autologous bone marrow transplantation in 22 adult patients with lymphoblastic lymphoma responsive to conventional dose chemotherapy. Bone Marrow Transplant 1992, 10:33\u201338.","journal-title":"Bone Marrow Transplant"},{"key":"5_CR33","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1200\/JCO.1994.12.7.1358","volume":"12","author":"JW Sweetenham","year":"1994","unstructured":"Sweetenham JW, Liberti G, Pearce R, et al.: High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European Group for Bone Marrow Transplantation. J Clin Oncol 1994, 12:1358\u20131365.","journal-title":"J Clin Oncol"},{"key":"5_CR34","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1200\/JCO.2001.19.11.2927","volume":"19","author":"JW Sweetenham","year":"2001","unstructured":"Sweetenham JW, Santini G, Qian W, et al.: High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation\/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group. J Clin Oncol 2001, 19:2927\u20132936.","journal-title":"J Clin Oncol"},{"key":"5_CR35","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/sj.bmt.1703891","volume":"31","author":"AJ Peniket","year":"2003","unstructured":"Peniket AJ, Ruiz de Elvira MC, Taghipour G, et al.; European Bone Marrow Transplantation (EBMT) Lymphoma Registry: An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation. Bone Marrow Transplant 2003, 31:667\u2013678.","journal-title":"Bone Marrow Transplant"},{"key":"5_CR36","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1182\/blood-2002-05-1483","volume":"101","author":"JE Levine","year":"2003","unstructured":"Levine JE, Harris RE, Loberiza FR, et al.: A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. Blood 2003, 101:2476\u20132482.","journal-title":"Blood"},{"key":"5_CR37","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project","year":"1993","unstructured":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med 1993, 329:987\u2013994.","journal-title":"N Engl J Med"},{"key":"5_CR38","first-page":"1018","volume":"43","author":"L Kostakoglu","year":"2002","unstructured":"Kostakoglu L, Coleman M, Leonard JP, et al.: PET predicts prognosis after one cycle of chemotherapy in aggressive lymphoma and Hodgkin\u2019s disease. J Nucl Med 2002, 43:1018\u20131027.","journal-title":"J Nucl Med"},{"key":"5_CR39","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1182\/blood-2005-01-0272","volume":"106","author":"C Haioun","year":"2005","unstructured":"Haioun C, Itti E, Rahmouni A, et al.: [18F] fiuoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early tool for predicting patient outcome. Blood 2005, 106:1376\u20131381.","journal-title":"Blood"},{"key":"5_CR40","first-page":"3931","volume":"93","author":"MS Czuczman","year":"1999","unstructured":"Czuczman MS, Dodge RK, Stewart CC, et al.: Value of immunophenotyping in intensively treated adult acute lymphoblastic leukemia. Cancer and Leukemia Group B study 8364. Blood 1999, 93:3931\u20133939.","journal-title":"Blood"},{"key":"5_CR41","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1182\/blood-2002-10-3221","volume":"102","author":"AA Ferrando","year":"2003","unstructured":"Ferrando AA, Armstrong SA, Neuberg DS, et al.: Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: Dominance of HOX dysregulation. Blood 2003, 102:262\u2013268.","journal-title":"Blood"},{"key":"5_CR42","first-page":"2666a","volume":"88","author":"J Kurtzberg","year":"1996","unstructured":"Kurtzberg J, Keating M, Moore JO, et al.: 2-amino-9-B-Darabinosyl-6-methoxy-9H-guanine (GW506U; compound 506U) is highly active in patients with T-cell malignancies: results of a phase I trial in pediatric and adult patients with refractory hematological malignancies [abstract]. Blood 1996, 88:2666a.","journal-title":"Blood"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-006-0005-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11899-006-0005-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-006-0005-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T09:49:54Z","timestamp":1587548994000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11899-006-0005-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["5"],"URL":"https:\/\/doi.org\/10.1007\/s11899-006-0005-8","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}